{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:14:57Z","timestamp":1783617297160,"version":"3.55.0"},"reference-count":52,"publisher":"Radcliffe Medical Media Ltd","issue":"3","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interv Cardiol"],"abstract":"<jats:p>Newer-generation drug-eluting stents (DES) are the standard of care for the treatment of symptomatic coronary artery disease. However, some lack of efficacy has been reported in small coronary arteries based on higher rates of target lesion restenosis, thrombosis and MI resulting in repeated interventions. Drug-coated balloons (DCBs) are an established treatment option for in-stent restenosis in both bare metal stents and DES and they can deliver an anti-proliferative drug into the vessel wall without implanting a stent. DCBs are a promising technique for selected de novo coronary lesions, especially in small vessel disease. In this article, the current evidence for the treatment of small vessel disease with DCBs will be reviewed.<\/jats:p>","DOI":"10.15420\/icr.2019.06.r3","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T06:40:27Z","timestamp":1575960027000},"page":"131-136","source":"Crossref","is-referenced-by-count":18,"title":["Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review"],"prefix":"10.15420","volume":"14","author":[{"given":"Thomas","family":"Nestelberger","sequence":"first","affiliation":[{"name":"Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raban","family":"Jeger","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"ESC Scientific Document Group, 2018 ESC\/EACTS guidelines on myocardial revascularization","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty","DOI":"10.1056\/NEJM197907123010201"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease","DOI":"10.1056\/NEJM199408253310802"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Colombo A, Giannini F, Briguori C. Should we still have bare-metal stents available in our catheterization laboratory? J Am Coll Cardiol 2017;70:607-19.","DOI":"10.1016\/j.jacc.2017.05.057"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","DOI":"10.1056\/NEJMoa032441"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"State of the art: balloon catheter technologies - drug-coated balloon","DOI":"10.4244\/EIJ-D-17-00494"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies","DOI":"10.1016\/j.jacc.2004.01.039"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis","DOI":"10.1016\/j.jcin.2016.03.025"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels","DOI":"10.1016\/S0735-1097(98)00444-6"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Vessel size and long-term outcome after coronary stent placement","DOI":"10.1161\/01.CIR.98.18.1875"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Stent placement for non-STRESS\/BENESTENT lesions: a critical review","DOI":"10.1002\/1522-726X(200010)51:2<223::AID-CCD21>3.0.CO;2-F"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. O'Connor NJ, Morton JR, Birkmeyer JD, et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1996;93:652-5.","DOI":"10.1161\/01.CIR.93.4.652"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography","DOI":"10.1136\/heartjnl-2013-304933"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Predictors of restenosis after coronary stent implantation","DOI":"10.1016\/S0735-1097(98)00076-X"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","DOI":"10.1056\/NEJMoa061254"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","DOI":"10.1016\/S0140-6736(12)61964-3"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","DOI":"10.1016\/S0140-6736(18)31719-7"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","DOI":"10.1186\/2046-4053-4-1"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Mohiaddin H, Wong T, Burke-Gaffney A, Bogle RG. Drug-coated balloon-only percutaneous coronary intervention for the treatment of de novo coronary artery disease: a systematic review. Cardiol Ther 2018;127-49.","DOI":"10.1007\/s40119-018-0121-2"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Percutaneous coronary intervention for small vessel coronary artery disease","DOI":"10.1016\/j.carrev.2009.04.007"},{"key":"ref20","unstructured":"21. Biondi-Zoccai GGL, Sangiorgi GM, Antoniucci D, et al. Taxus in real-life usage evalutaion study, testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE). Int J Cardiol 117:349-54."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Briguori C, Tobis J, Nishida T, et al. Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries. Eur Heart J 23:247-54.","DOI":"10.1053\/euhj.2001.2730"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Biondi-Zoccai GGL, Sangiorgi GM, Chieffo A, et al. Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era. Am J Cardiol 95:1466-8.","DOI":"10.1016\/j.amjcard.2005.01.099"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111:3435-42.","DOI":"10.1161\/CIRCULATIONAHA.104.513952"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial","DOI":"10.1016\/j.jacc.2004.11.063"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration","DOI":"10.1016\/j.phrs.2014.12.003"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"An update on the clinical use of drug-coated balloons in percutaneous coronary interventions","DOI":"10.1517\/17425247.2016.1154530"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data","DOI":"10.1016\/j.ijcard.2016.06.079"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic swine","DOI":"10.1161\/CIRCINTERVENTIONS.110.960260"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter","DOI":"10.4244\/EIJV9I1A21"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system","DOI":"10.4244\/EIJY15M10_01"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","DOI":"10.1016\/j.jcin.2012.01.008"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study","DOI":"10.4244\/EIJY14M08_12"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","DOI":"10.1016\/j.jacc.2012.01.015"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis","DOI":"10.1016\/j.jcin.2010.10.012"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials","DOI":"10.1136\/heartjnl-2012-302945"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Alfonso F, Garc\u00eda-Guimaraes M, Navarrete G, et al. Drug-eluting balloons in coronary interventions: the quiet revolution? Expert Opin Drug Deliv 2017;14:841-50.","DOI":"10.1080\/17425247.2017.1245291"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"everolimus-elutining stent)","DOI":"10.1016\/j.jacc.2013.12.006"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Cai JZ, Zhu YX, Wang XY, et al. Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials. BMJ Open 2018;8:e017231.","DOI":"10.1136\/bmjopen-2017-017231"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions","DOI":"10.1016\/j.jcin.2012.08.005"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Picard F, Doucet S, Asgar AW. Contemporary use of drug-coated balloons in coronary artery disease: where are we now? Arch Cardiovasc Dis 2017;110:259-72.","DOI":"10.1016\/j.acvd.2017.01.005"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"The PICCOLETO study","DOI":"10.1136\/hrt.2010.195057"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease","DOI":"10.1111\/joic.12333"},{"key":"ref44","unstructured":"45. Sim HW, Ananthakrishna R, Chan SP, et al. Treatment of very small de novo coronary artery disease with 2.0 mm drug-coated balloons showed 1-year clinical outcome comparable with 2.0 mm drug-eluting stents. J Invasive Cardiol 2018;30:256-61."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Venetsanos D, Lawesson SS, Panayi G, et al. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Catheter Cardiovasc Interv 2018;92:E317-26.","DOI":"10.1002\/ccd.27548"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Cortese B. The PICCOLETO study and beyond. EuroIntervention 2011;7:K53-6.","DOI":"10.4244\/EIJV7SKA9"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model","DOI":"10.1007\/s00392-009-0008-2"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","DOI":"10.1016\/j.jacc.2012.09.020"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Colombo, 3-year follow-up of the Balloon Elution and Late Loss Optimization study (BELLO)","DOI":"10.1016\/j.jcin.2015.04.008"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial","DOI":"10.1016\/j.jcin.2018.09.009"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52. Megaly M, Rofael M, Saad M, et al. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv 2019;93:E277-86.","DOI":"10.1002\/ccd.27996"}],"container-title":["Interventional Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.icrjournal.com\/articles\/Drug-coated-Balloons-for-Small-Coronary-Vessel-Interventions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:46:15Z","timestamp":1783615575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2019.06.R3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.15420\/icr.2019.06.r3","relation":{},"ISSN":["1756-1485","1756-1477"],"issn-type":[{"value":"1756-1485","type":"electronic"},{"value":"1756-1477","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,18]]}}}